The Practitioner 1, 2023

The Practitioner Published by the Florida Association of Equine Practitioners, an Equine-exclusive Division of the FVMA

Issue 1 • 2023

MANAGING EQUINE PLACENTITIS

From a One Health Perspective Sara K. Lyle | DVM, MS, PhD, DACT | Page 6

Quit Your Bellyaching:

COLIC IN THE EQUINE NEONATE

Tiffany L. Hall | DVM, DACVIM, DACVECC Nimet Browne | DVM, MPH, DACVIM | Page 14

MANAGING DIFFICULT CLIENTS

and Difficult Expectations

Martha Mallicote | DVM, MBA, DACVIM | Page 22

The President's Line Dear fellow practitioners,

EXECUTIVE COUNCIL

RUTH-ANNE RICHTER

BSc (Hon), DVM, MS FAEP COUNCIL PAST PRESIDENT

rrichter@brandonequine.com

ADAM CAYOT DVM

adamcayot@hotmail.com

SALLY ANNE DENOTTA

DVM, PhD

s.denotta@ufl.edu

The arrival of spring means our busy season has begun once more! With the veterinary workforce crisis, the equine field has seen a decline in veterinarians. Those of us in the industry are pushing harder than ever – with increased workloads – to care for the equines around us and manage our clients. Sometimes, we may find ourselves overextended. It is my hope that we will utilize what we learned in the last issue exercise clear communication with our clients about our abilities and time constraints. If you are ever struggling, please reach out to the FVMA/FAEP, and we will help connect you with valuable resources.

Topically, this issue of The Practitioner features information on placentitis, foals, and managing difficult clients.

As always, I look forward to seeing you all at our flagship equine conference, Promoting Excellence Symposium (PES), to be held Oct. 19-22, 2023, in West Palm Beach, FL, at the Hilton West Palm Beach. Offering world-class continuing education, PES 2023 features renowned speakers and a wet lab that will provide comprehensive instruction and lead participants in hands-on learning.

Kind regards,

COREY MILLER DVM, MS, DACT

cmiller@emcocala.com

Armon Blair, DVM Ocala Equine Hospital FAEP Council President abeqdoc@gmail.com

ANNE L. MORETTA

VMD, MS, CVSMT, CVA

maroche1@aol.com

JACQUELINE S. SHELLOW

If anyone is struggling with mental wellness, please do not hesitate to reach out to colleagues, friends, or the FAEP (call 800-992-3862).

jackie@shellow.com

Our Membership Assistance Program (MAP), which is free for all members, offers personal and professional consultation to help you be your best. More information and wellness resources can be found at fvma.org

DVM, MS FVMA PRESIDENT

Opinions and statements expressed in The Practitioner reflect the views of the contributors and do not represent the official policy of the Florida Association of Equine Practitioners (FAEP) or the Florida Veterinary Medical Association (FVMA), unless so stated.

Placement of an advertisement does not represent the FAEP’s or FVMA’s endorsement of the product or service.

FAEP | 7207 MONETARY DRIVE, ORLANDO, FL 32809 | PH: 800.992.3862 | FAX: 407.240.3710 | EMAIL: INFO@FVMA.ORG | WEBSITE: WWW.FVMA.ORG

2 The Practitioner

Issue 1 • 2023

Become an FAEP MEMBER The FAEP is the equine-exclusive division of the FVMA. The FAEP is focused on supporting the professional development of its members and providing them with world-class, equine-exclusive continuing education through two annual conferences.

MEMBERSHIP BENEFITS include: ■ Discounts on Continuing Education Members have access to online courses and conferences for affordable CE opportunities. Our yearly equine events include Ocala Equine Conference (OEC) and Promoting Excellence Symposium (PES). These conferences expand the skills and knowledge of attendees through lectures and hands-on wet labs while offering a chance to network with colleagues and industry partners.

■ Complimentary Legal Consultations Members have always been able to ask our legal team questions on practicing veterinary medicine, pharmacy law, and veterinary board relations. Our legal benefits have expanded in 2023 to include new areas of law such as labor and employment law and civil litigation.

■ Discounts on Services and Goods

Scan here or call 800-992-3862 TO BECOME AN FAEP MEMBER TODAY!

FAEP members have access to exclusive discounts on merchant services, professional services , digital marketing tools, and travel and entertainment. These include: ■ Clover Merchant Services for electronic payments.

■ CareCredit for client financing and payment options.

■ Social Ordeals for digital marketing and reputation management.

■ Working Advantage for deals on everything from theme park tickets to rental cars, movie tickets, streaming services, and more.

Membership Pricing MEMBERSHIP TYPE

FEE

Regular Member

$299

Recent Graduate (2021-2022)

$199

Part-time Employed

$199

State/Federal Employee

$199

Non-resident Member

$135

Retired Member*

$120

**FAEP Bylaws state: Any veterinarian who has been (a) an active member of the Association or any other state veterinary association for at least the past 15 years, (b) has reached the age of 65, (c) and who may be engaged in the practice of veterinary medicine on an average of less than a total of ten (10) hours per week. Retired members shall have all the privileges of full membership.

Member Spotlight THE FUTURE OF VETERINARY MEDICINE:

Taylor McLendon, DVM Jillian Sinclair | Marketing Specialist Florida Veterinary Medical Association

Dr. Taylor McLendon grew up in Saint Augustine, FL, where her interest in horses first began. Keeping to her Florida roots, she received both her bachelor's degree in animal biology and doctorate in veterinary medicine from the University of Florida (UF). During her time at the UF College of Veterinary Medicine (UFCVM), Dr. McLendon served as class president all four years and as the president of UF’s chapter of the Student American Veterinary Medical Association (SAVMA). Continuing her love for learning and leadership, Dr. McLendon is currently enrolled in the FVMA’s Power of Ten program, which is designed to develop skills in leadership and entrepreneurship for Florida veterinarians. She is also a member of the AVMA, AAEP, FAEP, and FVMA.

TURNING PASSION INTO A CAREER Her love for horses began as a child while competing in Western performance events. This is where her passion for the equine athlete began and why she has devoted her career to this field. Her practice largely focuses on lameness and sports medicine of the performance horse.

Dr. McLendon currently owns and operates Mandarin Equine Veterinary Service in Jacksonville, FL. During her

4 The Practitioner

fourth year of veterinary school, she accepted a position working at the practice, which was then owned by her lifelong mentor, Dr. Peggy Fuller. While most recent graduates start their career with an internship, Dr. McLendon went straight into field work at the practice. After three years working as an associate, she purchased the practice in July of 2022 and is now the sole practice owner and only practitioner. Dr. McLendon has big goals for her business and is looking to expand and grow the practice.

Issue 1 • 2023

PLANS FOR THE FUTURE She hopes to expand Mandarin Equine to a three-doctor practice, while keeping the focus on sports medicine and lameness. Her five-year plan includes adding to the ambulatory services and increasing the staff size. Her goal is to continue to offer innovative diagnostic and treatment options that will best serve the performance horse. She is heavily involved in continuing education opportunities and is an advocate for advancing veterinary medicine and techniques in her field.

Dr. McLendon is very interested in the business side of the veterinary industry as well. She enjoys running her practice and working on the financial and management side of the business rather than just focusing on practicing veterinary medicine.

A FAMILY AFFAIR Dr. McLendon is a truly family-oriented individual – and she brings that into her work as much as possible. One of her sisters, Adison, works as the practice manager at Mandarin Equine and her youngest sister, Meghan, is currently in her second year of veterinary school at UF. Meghan is also focused on veterinary medicine and plans to join Dr. McLendon's practice after graduating in 2025. Dr. McLendon is even going to be coating Meghan at her White Coat Ceremony.

“This [coating Meghan] will absolutely be a core memory that stays with me forever. There is nothing that means more to me than being a part of her journey into the best profession,” said Dr. McLendon.

Dr. McLendon is married to her husband, Josh. They have a two-year-old son, Grady, and recently welcomed their daughter, Evan Shea, in March 2023. She loves that her job allows her to work with her family daily and is thankful to have a career that allows her to have a work-life balance, especially while starting her family.

ADVICE FOR NEWER VETERINARIANS When asked what advice she would give to someone who is just starting their career in veterinary medicine, Dr. McLendon said: “Your career does not have to (and should not) consume your entire life. This profession has so much to offer and can be incredibly rewarding. However, it’s entirely possible to have a work-life balance. I think the current mindset is that in order to be an exceptional vet, you must make personal sacrifices, and I could not disagree more. I run a very successful practice, I have close personal relationships with many of my clients, and (even more importantly) I do everything in my power to be the best mother and wife that I can be. Being an excellent vet does not mean working yourself to the point of burnout. It means taking care of yourself first so that you are healthy and strong enough to serve your patients.” www.fvma.org |

Images courtesy of Dr. Taylor McLendon.

thefaep |

@thefvma | The Practitioner 5

Placentitis MANAGING EQUINE PLACENTITIS

From a One Health Perspective Sara K. Lyle | DVM, MS, PhD, DACT North Carolina State University - College of Veterinary Medicine

Over the last three decades, research on equine placentitis has undoubtedly provided great insights into this frustrating problem. This article will review the pathogenesis, diagnosis, and treatment of placentitis.

Recent findings on therapeutics, with a special focus on the prolonged nature of antibiotic administration, will open a discussion on how this arm of multi-modal placentitis therapy impacts One Health.

INTRODUCTION After expending considerable time in establishing pregnancy in the sub-fertile mare, it is imperative that she be adequately monitored to detect complications in the later part of gestation.

The most likely complication to arise during the last third of gestation in the sub-fertile mare would be placentitis. Timely identification of placentitis is crucial for multi-modal therapy to be successful. Other potential reproductive causes of high-risk pregnancy such as intrauterine growth retardation and cord abnormalities might also be identified.

Placentitis has been reported to be responsible for 9.8, 19.4, 24.7, and 33.5%1, 2, 3, 4 of abortions, stillbirths, and perinatal losses in horses. Bacterial infections are responsible for 53% of these losses; Streptococcus equi subsp. zooepidemicus (S. zooepidemicus) was isolated in 28% of these cases.3 Other bacteria frequently identified were Escherichia coli, Leptospira spp., Crossiella equi, Pseudomonas spp., S. equisimilis, Enterobacter spp., Klebsiella spp., α-hemolytic streptococci, Staphylococcus spp., and Actinobacillus spp.3 Infection was localized to the cervical star in 95% of cases, supporting the argument that ascension of aerobic bacteria through the vagina and cervix is the most frequent route of infection (Fig. 1A).5 Clinical signs include vulvar discharge, udder development, prenatal lactation, and premature delivery or stillbirth. Abortions can occur from 75 days to term,5 although

6 The Practitioner

the majority of clinical cases are presented to practitioners during the third trimester. In a survey of 200 fetal membranes with infective placentitis, 36% of those with bacterial infections were recorded to have had premonitory signs, compared to 63% of those with fungal infections.5 A notable exception to the transcervical ascension of pathogens is focal mucoid placentitis (“nocardioform placentitis”) caused by actinomycetes (Fig. 1B). Most isolates have been C. equi,6 although other species have been identified, including Amycolatopsis spp., Streptomyces spp., and Cellulosimicrobium cellulans. Although sporadic cases of nocardioform placentitis have been reported in South Africa, Florida, and Italy,7-9 most reported cases are from Kentucky. Inflammation of the chorion extends from the cranial ventral uterine body, usually at the base of the gravid horn, with an adherent tan to brown mucoid exudates.10 Precocious udder development is occasionally observed with nocardioform placentitis, but vaginal discharge is uncommon. The majority of abortions occur during the ninth and tenth month of gestation.

Interestingly, other non-nocardioform bacteria have been isolated from lesions that are grossly indistinguishable from nocardioform placentitis,11 so perhaps the gross appearance of this form of placentitis is unique to its distribution pattern rather than the causative agent.

Issue 1 • 2023

A

B

Figure 1. Examples of chorioallantoic membranes with ascending (A) or focal mucoid (B) placentitis. Note the relationship between the affected area of the chorionic surface and the cervical star.

Images courtesy of Neil Williams.

MONITORING THE HIGH-RISK PREGNANCY Ultrasonography is a key diagnostic modality for diagnosing disturbances of the feto-placental unit and for monitoring the progression of fetal viability and placental changes. Evaluations are made both transrectally and transabdominally and are best performed when the mare is restrained in stocks in a quiet environment. Mare agitation or anxiety can produce fetal tachycardia without concomitant fetal movements. Sedation is also to be avoided, due to the associated fetal bradycardia.

Hormonal profiling can provide crucial information and is complimentary to the information gained by ultrasonography.

Other modalities that can be used include centesis of fetal fluids, and echocardiography. Ultrasonography replaced fetal echocardiography to monitor fetal heart rate.

Transrectal Ultrasonography – For transrectal examination, a 5.0- to 7.5-MHz linear-array transducer is positioned just cranial to the junction of the cervix and the uterine body. Small lateral movements are made until a vessel on the ventral border of the uterus is located. This vessel is variably described in anatomy texts, but most commonly is designated as the uterine branch of the vaginal artery, which is a branch of the internal pudendal artery. Several measurements are taken from the leading edge of the allantoic surface to the leading edge of the blood vessel

and averaged. An increase in the combined thickness of the uterus and placenta (CTUP), especially with concomitant accumulation of echogenic fluid between the endometrial and chorionic surfaces, is characteristic of placentitis (Fig. 2). If serial monitoring is anticipated, it is beneficial to consistently measure the CTUP at the same distance from the cervix during each examination. Upper limits of the normal CTUP have been established;12 finding increases in the CTUP of >8 mm during the ninth month, >10 mm during the tenth month, and >12 mm after day 330 signals that placental failure and abortion may occur.13, 14 Certain circumstances can lead to CTUP values being greater than is considered normal in the absence of placentitis.

Episodes of high fetal and uterine activity, especially when the fetus becomes positioned in the caudal uterine body, can produce CTUP values that are above the normal range for that stage of gestation. Apposition of the amnion with the allantois produces a slight increase in the CTUP. Allantoic fluid is hypoechoic in comparison to amniotic fluid with small hyperechoic foci (“vernix”) suspended in the anechoic medium. Vernix is also present in the amniotic fluid, but it is somewhat less obvious due to the overall greater echogenicity of amniotic fluid compared to allantoic fluid. This hypoechogenicity of the allantoic fluid persists until parturition nears, while the amniotic fluid gradually increases in echogenicity during the last month of gestation.12 Increased echogenicity of the allantoic fluid coincided with the first day of recovery of bacteria from allantoic fluid with experimental infection.15 Edema of the chorioallantois at term

www.fvma.org |

thefaep |

@thefvma | The Practitioner 7

serial examinations are anticipated, clipping of the abdomen is recommended, followed by application of alcohol and coupling gel.

If the abdomen has been clipped, then scanning can be performed in either a caudalto-cranial or cranial-to-claudal direction. If the belly was not clipped, then scanning in a cranial-to-caudal direction avoids “ruffing up” the hair, which increases air interference and reduces image quality. Scanning should begin at the ventral midline, evaluating in parallel parasagittal planes from the mammary gland to the umbilicus or sternum depending on the stage of pregnancy.

Baseline FHRs in the last weeks of pregnancy are 60–75 bpm with a range of 40–250 bpm.

Low or high FHRs are cause for alarm if they are persistent with no accelerations or decelerations or accelerations that are unaccompanied by fetal movement.17 Fetal activities (e.g., movement, breathing, swallowing, sucking) should be noted and Figure 2. Transrectal ultrasonography of the caudal uterine segment demonstrates either scored subjectively or quantified as measurement of the combined thickness of the uterus and placenta. Measurements of the CTUP (dashed line) and the depth of exudate accumulation (dotted line). the number of movements in a given time Image courtesy of Sara K. Lyle. period. Fetal presentation is confirmed based on the orientation of the fetal thorax relative to the maternal pelvis. In addition to flexion and extension of the extremities, other more extreme motion patterns can sometimes be observed: rotation is normal and simply indicates impending parturition. Edema of on the short axis (spinning) or long axis (rolling) and whole the chorioallantois, or a discernible difference in the echogenicity body shifting vertically or horizontally (translation). The fetus of the uterine wall and the chorioallantois at other times, should is able to change presentation through the first eight months be considered as an indicator of potential premature delivery. of gestation. Since cases of nocardioform do not have vulvar Chorioallanotic edema was seen with experimentally induced 16 discharge or increases in the CTUP of the caudal uterine segment, placentitis in the 24 hours preceding abortion. Fetal presentation transabdominal ultrasound has the best chance of making a is easily confirmed by identifying the presence (anterior) or diagnosis. Unfortunately, it can be difficult to locate the area of absence of (posterior) the fetal orbit. separation of the chorioallantois from the endometrium, so false negative results are commonly encountered.

Transabdominal Ultrasonography – For transabdominal ultrasonography, a 3.5- to 5.0-MHz sector-array transducer is Identification of cord abnormalities such as long cord/cord preferred. In very late gestation or in heavy breed mares, a 2- to torsion may on occasion be detected with transabdominal 2.5-MHz sector-array transducer may allow for greater access to ultrasonography, especially with the use of Doppler technology. the fetus. Transabdominal ultrasonography is useful for assessing Unfortunately, only short segments of the cord can usually be fetal heart rate (FHR), fetal activity, fetal presentation and imaged at a time, which lessens the likelihood of detecting cord position, character, and depth of fetal fluids, as well as increased abnormalities prior to abortion. Likewise, assessment of in-utero CTUP in cases of placentitis not due to ascension through the growth retardation (small for gestational age) can be estimated cervix (e.g., nocardioform placentitis or hematogenous infection). by measuring the fetal aortic diameter, which is significantly For single transabdominal evaluations, the hair of the ventral correlated with neonatal foal weight. Fetal aortic diameter is abdomen should be cleaned of all dirt and debris, and alcohol and measured during systole from leading edge to leading edge as ultrasound coupling gel applied liberally. In patients for whom

8 The Practitioner

Issue 1 • 2023

it emerges from the heart. Fetuses with substantial deviations from the mean aortic diameter for the stage of gestation may be small for gestational age;18 however, this may not be a very reliable predictor of in-utero growth retardation.

Allantocentesis/Amniocentesis – Although amniocentesis is commonly used by physicians to diagnose chorioamnionitis in women and assess fetal maturity, allantocentesis is rarely used in cases of suspected placentitis in the mare either to document infection in the fetal fluid compartments or to ascertain readiness for birth. Lecithin to sphingomyelin ratio (L:S) and lamellar body count in amniotic fluid have been used in human medicine to predict the presence of phosphatidylglycerol, a marker for fetal lung maturity.19 The L:S and lamellar body count in amniotic fluid in healthy equine term neonates have been measured;20 however, neither the L:S nor the percentage phosphatidylglycerol were found to provide useful antepartum predictors of fetal maturity from day 292 to term.21 In experimental models of placentitis, PGF2α and PGE215, 22 and cortisol23 were found to be elevated prior to pre-term delivery. Because PGF2α and PGE2 are labile and require strict and cumbersome sample handling to avoid analyte degradation, measurement of prostaglandins in fetal fluids is not practical. Elevated cortisol concentrations in fetal fluids signal that the fetal hypothalamic-pituitary-adrenal axis has been prematurely activated and that delivery may be impending. Until reliable markers for fetal maturity and for infection are identified, the use of allantocentesis in the diagnosis and management of placentitis should be undertaken with caution. Continued research is needed to identify reliable indicators of equine fetal maturity.

In mares with suspected hydropic pregnancy, the concentrations of creatinine and chloride are useful in determining whether hydrops allantois or hydrops amnii is present. During the last four months of pregnancy, chloride is significantly higher in amniotic than in allantoic fluid (112.3 - 0.5x and 37.3 + 0.3x mM respectively, where x is the days prepartum), while creatinine is significantly lower in amniotic than in allantoic fluid (12.796 + 0.26x + 0.0008x2 and 1000.96 + 2.574 +x + 0.014x2 mg/dl respectively, where x is the days prepartum). 24 Calcium was significantly increased in both fetal fluid compartments with impending term parturition; however, calcium was decreased in pregnancies following intrafetal betamethasone administration, questioning the usefulness of fetal fluid calcium concentration as a determinant for readiness for birth in preterm pregnancies.24 Hormonal Profiling and Biomarkers – Several hormones in the maternal circulation may be useful to monitor during high-risk pregnancies. Total progestins are commonly measured in pregnant mares, although single samples probably are not as informative as serial samples. Total maternal plasma progestins (as measured by cross-reactivity with a progesterone assay) are low (2-12 ng/

mL) until the last 15-21 days of gestation, climb substantially, and then fall abruptly within 24 hours of parturition.25, 26 Precocious increases in progestins prior to day 315 may be seen with placentitis; acute declines in progestagens are associated with fetal demise and impending abortion.27, 28 It is crucial that samples be submitted to a laboratory that has established values for progestins in the late-term mare. Each progesterone assay has different cross-reactivities with the various progestagens, so it is not possible to compare values from one laboratory with ranges established by another laboratory, which uses a different assay. Estrone sulfate can be used to monitor fetal well-being, but it is not sensitive in detecting the early stages of placentitis.

From day 150 to 310, total estrogens (predominately conjugated estrogens) are greater than 1000 pg/mL, falling to 500 pg/mL by day 340; mares with total progestins greater than 15 ng/mL and total estrogens less than 500 pg/mL between days 150 and 280 aborted, while those with progestins less than 8 ng/mL and total estrogens greater than 1000 pg/mL during this same time frame delivered live foals.29 Relaxin is produced by the placenta, and it has been found to be decreased in mares with placentitis or signs of endophyte-infected fescue toxicosis.30 Unfortunately, at this time no commercial assay is available for relaxin. Recently the concomitant profiling of progestins, estrogens (predominately estradiol 17-β), and foal outcome were reported with the following cutoffs to distinguish healthy and foal loss groups for different timeframes of days 240 to term.31 See Table 1.

Table 1

Progesterone and estradiol cut off values to distinguish healthy foal and foal loss groups. Adapted from Shikich M, et al., 2017 [31].33

Gestational age (days)

Progesterone (ng/mL)

Estradiol 17-β (pg/mL)

221 - 240

7.94

379

241 - 260

5.51

153

261 – 280

4.87

192

281 - 300

7.47

171

301 – 320

10.4

69.9

321 –

28.4

63.3

Considerable effort has been made in identifying a biomarker, either in the allantoic fluid or the systemic circulation, which might provide an early diagnosis of placentitis. Serum amyloid A, lactate, α-fetoprotein, lactate, and metabolomics profile have all failed to be sensitive and specific for providing an earlier diagnosis in comparison to ultrasonographic examination.

www.fvma.org |

thefaep |

@thefvma | The Practitioner 9

Image courtesy of Shutterstock.

THERAPEUTICS FOR THE HIGH-RISK PREGNANCY The exact list of therapeutic agents needed for an individual mare will vary depending on the reason for the high-risk status.

Historically a few agents are commonly used in many highrisk mares: altrenogest, flunixin meglumine, pentoxifylline, and antibiotics. To provide supplemental progestagen support, the usual dosage of altrenogest is 0.044 mg/kg po q24h. In high-risk mares, increasing the dosage to 0.088 mg/kg q24h is thought to provide improved tocolytic activity (decreased uterine contractions). Long-acting injectable progesterone has become popular to avoid the need for daily altrenogest administration.

Caution is urged following the report of a one-month retention of a fetus following death.32 Injectable clenbuterol is a potent tocolytic agent but is not available in the U.S. Debate exists on

10 The Practitioner

whether oral clenbuterol (200 µg/kg) produces significant reduction in uterine contractions.

Flunixin meglumine, a cyclooxygenase inhibitor, prevents the production of prostaglandins stimulated by endotoxemia; it must be given in endotoxemia to avoid luteolysis, which in early pregnancy would lead to abortion.

Later in pregnancy, endotoxemia can directly compromise the fetoplacental unit resulting in abortion. Recent evidence indicates that firocoxib (Equioxx®) successfully suppresses prostaglandin and cytokine production in mares with placentitis, which provides a safer alternative when prolonged NSAID treatment is indicated.33 Pentoxifylline (8.5 mg progestagens and NSAIDs) appears to delay pre-term delivery in cases of placentitis.33 Vulvar discharges from mares with suspected placentitis are typically contaminated with commensal microbiota making isolation of the causative organism difficult. Broad-spectrum antibiotics (trimethoprim sulfa, ceftiofur, or penicillin and gentamicin) are indicated in these instances8,34 until identification and sensitivity are confirmed. Unfortunately, the potential efficacy of trimethoprim sulfa combinations35 and ceftiofur36 have recently been challenged.

Enrofloxacin, when administered at 7.5 or 15 mg/kg for 14 days starting at 280 days gestation, had no effect on advanced imaging, biomechanical testing, or gene expression of the foal cartilage at 30 days of age.

CONCLUSIONS Placentitis hinges on early recognition of infection. Unfortunately, the clinical symptoms of placentitis are not consistent, but a combination of serial ultrasonography and maternal hormonal profiling may allow for the earliest identification of mares with an abnormal feto-placental unit. Sub-fertile mares, or those with a history of previous ascending placentitis, should have serial examinations beginning no later than the start of the last trimester. In some cases, monitoring from mid-gestation onward would be prudent. Further research on biomarkers for identifying infection of the allantoic fluid prior to changes in the CTUP and the use of biologics for reducing the dependence and length of treatment with antibiotics will aid in improving outcomes of cases with placentitis and reduce the impact on OWOH.

Issue 1 • 2023

REFERENCES 1. Smith KC, Blunden AS, Whitwell KE, Dunn KA, Wales AD. A survey of equine abortion, stillbirth and neonatal death in the UK from 1988 to 1997. Equine Vet J; 2003;35(5):496-501.

2. Hong CB, Donahue JM, Giles RC, Jr, Petrites-Murphy MB, Poonacha KB, Roberts AW, et al. Etiology and pathology of equine placentitis. J Vet Diagn Invest; 1993;5(1):56-63.

3. Giles RC, Donahue JM, Hong CB, Tuttle PA, Petrites-Murphy MB, Poonacha KB, et al. Causes of abortion, stillbirth, and perinatal death in horses: 3,527 cases (1986-1991). J Am Vet Med Assoc; 1993;203(8):1170-5.

4. Hong CB, Donahue JM, Giles RC, Jr, Petrites-Murphy MB, Poonacha KB, Roberts AW, et al. Equine abortion and stillbirth in central Kentucky during 1988 and 1989 foaling seasons. J Vet Diagn Invest; 1993;5(4):560-6.

5. Whitwell KE. Infective placentitis in the mare. In: Powell DG,

editor. Equine Infectious Dieseases. Lexington, KY: University Press of Kentucky; 1988. p. 172-80.

6. Donahue JM, Williams NM, Sells SF, Labeda DP. Crossiella equi sp. nov., isolated from equine placentas. Int J Syst Evol Microbiol; 2002;52(Pt 6):2169-73.

7. Volkmann DH, Williams JH, Henton JH, Donahue JM, Williams NM. The first reported case of equine nocardioform placentitis in South Africa. J S Afr Vet Assoc; 2001;72(4):2358.

8. Christensen BW, Roberts JF, Pozor MA, Giguere S, Sells SF, Donahue JM. Nocardioform placentitis with isolation of Amycolatopsis spp in a Florida-bred mare. J Am Vet Med Assoc; 2006;228(8):1234-9.

9. Cattoli G, Vascellari M, Corro M, Capua I, Mutinelli F, Sells SF, et al. First case of equine nocardioform placentitis caused by

Image courtesy of Shutterstock.

www.fvma.org |

thefaep |

@thefvma | The Practitioner 11

Crossiella equi in Europe. Vet Rec; 2004;154(23):730-1.

10. Donahue JM, Williams NM. Emergent causes of placentitis and abortion. Vet Clin North Am Equine Pract; 2000;16(3):443-56, viii.

11. Williams NM. Equine placental pathology: The common and the not so common. Hilton Head, S.C.: Havemeyer Foundation, 2005.

12. Renaudin CD, Troedsson M, Gillis CL. Transrectal ultrasonographic evaluation of the normal equine placenta.

13. Equine Vet Educ; 1999;11(2):75-6.

14. Troedsson MHT, Renaudin CD, Zent WW, Steiner JV, editors. Transrectal ultrasonography of the placenta in normal mares and mares with pending abortion: A field study. 43rd Annual AAEP Convention Proceedings; 1997 December 7-10, 1997; Phoenix, AZ: American Association of Equine Practitioners.

15. Renaudin CD, Liu IKM, Troedsson MHT, Schrenzel MD. Transrectal ultrasonographic diagnosis of ascending placentitis in the mare: A report of two cases. Equine Vet Educ; 1999;11(2):69-74.

16. Lyle SK. The relationship between pro-inflammatory cytokines, prostaglandins, and fetal hypothalamic-pituitaryadrenal axis activation in mares with infective pre-term delivery [Dissertation]. Baton Rouge, LA: Louisiana State University; 2008.

17. Lyle SK. Unpublished observations. 2008.

18. Palmer JE, editor. Fetal monitoring. Society for Theriogenology Annual Conference; 2000; San Antonio, TX. 19. Bucca S, Fogarty U, Collins A, Small V. Assessment of fetoplacental well-being in the mare from mid- gestation to term: Transrectal and transabdominal ultrasonographic features.

Theriogenology; 2005;64(3):542-57.

20. Poggi SH, Spong CY, Pezzullo JC, Bannon PZ, Goodwin KM, Vink J, et al. Lecithin/sphingomyelin ratio and lamellar body count. What values predict the presence of phosphatidylglycerol? J Reprod Med; 2003;48(5):330-4.

21. Castagnetti C, Mariella J, Serrazanetti GP, Grandis A, Merlo B, Fabbri M, et al. Evaluation of lung maturity by amniotic fluid analysis in equine neonate. Theriogenology; 2007;67(9):1455-62.

22.Williams MA, Schmidt AR, Carleton CL, Darien BJ, Goyert GL, Sokol RJ, et al. Amniotic fluid analysis for ante- partum foetal assessment in the horse. Equine veterinary journal; 1992;24(3):236-8.

23. LeBlanc MM, Giguere S, Brauer K, Paccamonti DL, Horohov DW, Lester GD, et al. Premature delivery in ascending

12 The Practitioner

placentitis is associated with increased expression of placental cytokines and allantoic fluid prostaglandins E2 and F2alpha.

Theriogenology; 2002;58:841-4.

24. Lyle SK, Gentry LR, Horohov DW, Johnson JR, Eilts BE, Godke RA, et al. Preliminary evidence of fetal hypothalamicpituitary-adrenal axis activation in an experimental model of infective preterm delivery in the mare. Clinical Theriogenology; 2009;1:238.

25. Paccamonti D, Swiderski CE, Marx B, Gaunt S, Blouin D. Electrolytes and biochemical enzymes in amniotic and allantoic fluid of the equine fetus during late gestation. Biol Reprod; 1995;Mono Ser I:39-48.

26. Ousey JC, Forhead AJ, Rossdale PD, Grainger L, Houghton E, Fowden AL. Ontogeny of uteroplacental progestagen production in pregnant mares during the second half of gestation. Biol Reprod; 2003;69(2):540-8.

27. Ousey JC, Houghton E, Grainger L, Rossdale PD, Fowden AL. Progestagen profiles during the last trimester of gestation in Thoroughbred mares with normal or compromised pregnancies. Theriogenology; 2005;63(7):1844-56.

28. Morris S, Kelleman AA, Stawicki RJ, Hansen PJ, Sheerin PC, Sheerin BR, et al. Transrectal ultrasonography and plasma progestin profiles identifies feto-placental compromise in mares with experimentally induced placentitis.

Theriogenology; 2007;67(4):681-91.

29. Ousey JC. Hormone profiles and treatments in the late pregnant mare. Vet Clin North Am Equine Pract; 2006;22(3):727-47.

30. Douglas RH, editor. Endocrine diagnostics in the broodmare: What you need to know about progestins and estrogens.

Annual Conference Society for Theriogenology 2004 August 4-7, 2004; Lexington, KY. 31. Ryan PL, Christiansen DL, Hopper RM, Bagnell CA, Vaala WE, Leblanc MM. Evaluation of systemic relaxin blood profiles in horses as a means of assessing placental function in high-risk pregnancies and responsiveness to therapeutic strategies. Annals of the New York Academy of Sciences2009. p. 169-78.

32. McAfoos JL, Ellerbrock RE, Canisso IF. Fetal death associated with premature mammary gland development and lactation in a mare treated with weeky injections of longacting progesterone. J Eq Vet Sci, 2019;81:102783.

33. Shikichi M, Iwata K, Miyakoshi, Murase H, Sato F, Korosue K, Nagata S, Nambo Y. Abnormal pregnancies associated with deviation in progestin and estrogen profils in late pregnancy mares: A diagnostic aid. Theriogenology; 2017;98:75-81.

34. Macpherson ML, Giguere S, Pozor MA, Burden CA,

Issue 1 • 2023

Berghaus LJ, Berghaus RD, Varner JC, Hayna JT, Benson SM, Randell SA, Lyle SK, Kelleman AA, Hart KA, Mallicote MF, Horohov DW. Evidence for anti-inflammatory effects of firocoxib administered to mares with experimentally induced placentitis. A J Repro Immunol, 2021;86(1):1- 13.

35. Macpherson ML. Diagnosis and treatment of equine placentitis. Vet Clin North Am Equine Pract; 2006;22(3):76376.

Horses make us better.

Together, we make them better, too.

36. Ferrer MS & Palomares R. Aerobic uterine isolates and antimicrobial susceptibility in mares with post-partum metritis. Eq Vet J, 2018;50(2):202-207.

37. Mapherson ML, Giguere S, Pozor MA, Runcan E, Vickroy TW, Benson SA, Troedsson MHT, Hatzel JN, Larson J, vandenBerg E, Kelleman AA, Sanchez LC, LeBlanc MM. Pharmacokinetics of ceftiofur sodium in equine pregnancy. J Vet Pharmacol Ther;2017;40(6):656-662.

Sara K. Lyle,

DVM, MS, PhD, DACT Dr. Sara Lyle received her veterinary degree from the University of Florida, followed by a combined residency and master's program in theriogenology. She is a diplomate of the American College of Theriogenologists.

While on faculty at Louisiana State University’s School of Veterinary Medicine she completed a PhD focused on immunologic and endocrinologic aspects of infective pre-term delivery (placentitis) in mares. Currently, she is an associate professor of theriogenology at North Carolina State University’s College of Veterinary Medicine and the past president of the American College of Theriogenologists. She has authored numerous peer-reviewed articles and book chapters on equine and small animal reproduction. Her main clinical and research interests are in infectious infertility, highrisk pregnancy in the mare, contraceptive measures for wild and companion animal populations, assisted reproductive technologies, and non-invasive instrumentation for reproductive research.

ASERVO ® and EQUIHALER ® are registered trademarks of Boehringer Ingelheim Vetmedica GmbH, used under license. GASTROGARD ®, EQUIOXX®, MARQUIS ® and SURPASS ® are registered trademarks, and the Horse Head logo™ is a trademark of Boehringer Ingelheim Animal Health USA Inc. PRASCEND ® and VETERA ® are registered trademarks of Boehringer Ingelheim Vetmedica GmbH, used under license. ZIMECTERIN ® is a registered trademark of the Boehringer Ingelheim Group. ©2021 Boehringer Ingelheim Animal Health USA Inc., Duluth, GA. All rights reserved.

US-EQU-0199-2021

Colic

Quit Your Bellyaching:

COLIC IN THE EQUINE NEONATE

Tiffany L. Hall | DVM, DACVIM, DACVECC Equine Medical Center of Ocala

Nimet Browne | DVM, MPH, DACVIM Hagyard Equine Medical Institute

INTRODUCTION Abdominal pain is a relatively common problem encountered in the foal. Accurate and prompt diagnosis is critical to successful management, but it comes with unique challenges. Colic in a foal may look like the classic cockroach on its back or might present as dull and obtunded. To complicate evaluation, some routine diagnostics performed in an adult are not feasible in foals and, unlike adult horses, the degree of pain exhibited by a foal does not often correlate to the severity of the underlying lesion. Ultimately, similar decision-making criteria is required to determine the need for exploratory surgery in the neonate versus the adult horse.

Common differentials, diagnostic techniques, and treatment options will be discussed further in this article.

EVALUATION Signalment and history are invaluable when narrowing differentials for colic in the neonatal foal. For example, complications due to congenital abnormalities are often observed within the first few hours of life, while colic secondary to meconium retention or uroperitoneum usually presents within 24-48 hours of life. A thorough foaling history can raise suspicion of foaling injuries, which may present like colic pain, and a complete farm history may suggest infectious enterocolitis.

Physical examination is helpful to further differentiate causes of abdominal pain in the foal. Observation of the colicky foal can be extremely important as certain types of colic in the foal have a more typical outward appearance. Foals with gastric ulcers commonly lay on their back with their legs in the air, while a hunched-up position may indicate a caudal impaction. Foals which park out and appear straining could be trying to urinate

14 The Practitioner

Abdominal pain in foals can mimic the signs of Neonatal Maladjustment.

Image courtesy of Dr. Tiffany L. Hall.

Issue 1 • 2023

presence of fluid, gas, or meconium within the gastrointestinal tract, increased free abdominal fluid (with or without evidence of a ruptured bladder) as well as parasitism (older foals).

Radiographs can be beneficial in determining gas distension and the presence of meconium impactions. Contrast studies using barium enemas delivered by gravity can be diagnostic for atresia coli or meconium impaction in the small colon, while barium administered by nasogastric tube can identify pyloric or duodenal strictures. Abdominocentesis is slightly more challenging in the foal and should be performed with caution. Due to the relatively thin bowel wall, enterocentesis is more likely and can result in septic peritonitis, especially in the face of bowel distension. When performed, a blunt cannula should be used, and the fluid obtained submitted for testing which may include cytology, culture, and creatinine analysis.

Analysis of peritoneal fluid obtained via abdominocentesis may be used to assess intestinal health and/or confirm the diagnosis of uroabdomen.

Image courtesy of Dr. Tiffany L. Hall.

Specific conditions that cause acute abdominal pain in the neonate are widespread and encompass some of the same differentials that are seen in the adult. Disorders of the stomach, small intestine, and large colon are all seen in foals, but more unique disorders include meconium impactions, gastroduodenal ulcer syndrome, and uroperitoneum. A brief discussion of common conditions and field therapy, where appropriate, follows.

CONGENITAL CONDITIONS or indicate an urge to urinate associated with omphalitis or to relieve the weight of sand impaction. A complete physical examination includes vital parameters as well as auscultation of the thorax for typical “clicks” of a rib fracture or murmur of congenital cardiac abnormalities. Rib fractures can also be identified via palpation or imaging. As heart rate is influenced by several parameters, its value as a prognostic indicator is not as great in the foal compared to the adult. Nasogastric intubation can provide important information as in adult horses, but severe gastric distension can make intubation more challenging. Digital rectal examinations will replace the abdominal palpation per rectum and can provide information about meconium retention or the presence of diarrhea.

Occasionally meconium impactions may be palpated externally via deep abdominal palpation. Complete blood count, serum biochemistry, and immunoglobulin G concentrations should be performed to help identify the cause of abdominal pain and help rule out comorbidities.

As the equine neonate tends to be more demonstrative about pain than its adult counterpart, the vast majority of equine colic is non-surgical despite the severity of discomfort they may display.

Ultrasound of the foal’s abdomen provides information regarding gastrointestinal distension and motility, but may also identify the

Atresia ani is confirmed through physical examination of the perineum; atresia coli may be confirmed through contrast radiography; and congenital aganglionosis is suspected based on breed and phenotype.

ENTEROCOLITIS Enterocolitis accounts for approximately 40% of colic in foals presenting to referral institutions. As enterocolitis may appear similar to strangulating intestinal lesions depending on the individual’s pain response and is in a gray zone on diagnostic evaluation, we often initiate a period of therapy and assess response rather than moving immediately to surgery. Ideal therapy includes a period of gastrointestinal rest, antimicrobials, and supportive care. The identification of gas within the intestinal walls on ultrasound is a poor prognostic indicator.

MECONIUM IMPACTIONS Meconium impactions are one of the most common causes of colic in the equine neonate and are typically seen within the first 24 hours post-foaling. Normal passage of meconium should occur within the first few hours and may continue for 24-48 hours post-foaling. The administration of phosphate “Fleet” enemas within the first 12 hours can help prevent meconium impactions of the small colon. Meconium retention occurs in

www.fvma.org |

thefaep |

@thefvma | The Practitioner 15

the rectum, small colon, transverse colon, or large colon. Medical treatment is generally successful, but surgical intervention should be considered in cases of uncontrollable pain, peritoneal fluid abnormalities, and/or signs of bowel inflammation.

Medical management of impactions includes the administration of warm soapy water enemas by gravity feed using very soft tubing; however, clients must know not to administer serial enemas without consulting their veterinarian. Repeated enemas can result in mucosal irritation and associated “straining” in the absence of persistent impaction. I recommend not exceeding two enemas within 24 hours without veterinary intervention. If additional enemas are required, acetylcysteine is recommended.

Ultrasound image of distended amotile small intestine which may be observed in foals presenting with colic secondary to enterocolitis or strangulating obstruction.

Image courtesy of Dr. Tiffany L. Hall.

Enemas with acetylcysteine can be effective in breaking up impactions but can also cause tissue inflammation. Liquid acetylcysteine is available commercially as a 20% can be mixed with 160 ml of water and 20g of NaHCO3 to obtain a concentration of 4% and a pH of 7.6. Foals typically require sedation with midazolam, butorphanol, and/or xylazine for proper positioning in lateral recumbency. Elevation of the hind quarters can also help maintain fluid retention. The procedure requires introduction of a 30 Fr. Foley catheter with a 30 ml bulb approximately 2.5-5 cm into the rectum. The balloon is gently inflated until the anus and rectum are occluded. One hundred to 200 ml of 4% acetylcysteine is then administered by gravity flow and retained for approximately 30-45 minutes. The procedure can be repeated up to three times (one every 12-24 hours). Retrospective studies have shown this procedure to reduce the requirement for surgery in almost all cases.

GASTRODUODENAL ULCER SYNDROME

Ultrasound image of intussusception in a five-day-old foal.

The parts of the intussusception are as follows: redundant mucosa within lumen (green arrow), intussusceptum (orange), intussuscipiens (yellow).

Image courtesy of Dr. Tiffany L. Hall.

16 The Practitioner

The prevalence of equine gastric ulcer syndrome (EGUS) in neonatal foals is estimated to be approximately 25% to 50%.

The four clinical syndromes seen in foals are subclinical, clinical, perforating, and outflow obstruction with a pyloric stricture.

Clinical signs include lethargy, colic, bruxism, ptyalism, unthriftiness, frequent recumbency, and rolling into dorsal recumbency. Affected foals are typically two to six months of age; however, gastric ulceration is common in neonates presenting for concurrent disease (e.g., gastrointestinal, sepsis, maladjustment). The pathophysiology of gastric ulceration in foals includes physiologic stress, hypoxia, delayed gastric emptying, prolonged time between feedings, small meal size, and prolonged recumbency. NSAIDs inhibit the production of protective prostaglandins and therefore predispose the equine neonate to glandular ulceration. In addition, illness increases the risk of ulceration by decreasing gastric mucosal defenses secondary to decreased blood flow.

Issue 1 • 2023

Omeprazole is not recommended for use in neonates as ill neonates often have increased gastric pH; sucralfate administration is recommended instead.

UROPERITONEUM Foals may develop uroperitoneum secondary to traumatic bladder rupture, septic necrosis of the bladder wall, leakage or rupture from the internal urachus, congenital abnormalities of the ureters, or urethral rupture. Foals may present with frequent posturing to urinate, abdominal distension, or obtundation depending upon the severity of electrolyte derangements.

Diagnosis may be suspected based upon identification of free peritoneal fluid on ultrasound and confirmed by laboratory analysis of blood and peritoneal fluid. Surgery is often recommended; however, some foals may be managed medically with an indwelling urinary catheter.

SAND INGESTION In Florida, it is not uncommon to see neonates and older foals present for colic or diarrhea associated with pica, particularly ingestion of sand. These foals often display signs of colic through posturing as if to urinate and occasionally have significant abdominal distension. Diagnosis is confirmed via radiography and treatment involves supportive care and prolonged psyllium administration. Oral administration of psyllium may be accomplished by mixing a concoction of psyllium, yogurt, and applesauce. Surgery is rarely required, and recurrence is prevented through controlled management of the environment. Foals will often grow out of this habit within the first few months of age.

CONCLUSION Neonatal colic is common, and the degree of pain demonstrated is often not indicative of the severity of the underlying cause.

Both gastrointestinal and extra GI causes must be considered, and possible in many cases; however, consideration of owner capabilities and the proclivity of foals to decline rapidly should be taken into account. Indicators for referral include the presence of gastrointestinal reflux, lack of nursing, moderate abdominal distension, refractory pain, intestinal distention, or free fluid on ultrasonography, and/or altered mentation.

REFERENCES 1. Bohanon TC. Colic in the Equine Neonate. Proceeding NAVC North Am Vet Conf 2005:129–131.

2. Camacho-Luna P, Buchanan B, Andrews FM. Advances in Diagnostics and Treatments in Horses and Foals with Gastric and Duodenal Ulcers. Vet Clin North Am - Equine Pract 2018;34:25–38.

3. Cribb NC, Coté NM, Bouré LP, et al. Acute small intestinal obstruction associated with Parascaris equorum infection in young horses: 25 cases (1985-2004). N Z Vet J 2006;54:338– 343.

4. Furr M. Part VII Diagnosis of Colic in the Foal - Signalment and History. In: The Equine Acute Abdomen.; 2017:413–417.

5. Lewis S. Gastric ulceration in an equine neonate. Can Vet J 2003;44:420–421.

6. McAuliffe SB. Abdominal ultrasonography of the foal. Clin Tech Equine Pract 2005.

7. McClure S, Faber N, Mealey R. Diagnosing and correcting an intussusception of the small colon in a foal. Vet Med 1995:177–981.

8. Neal HN. Foal colic: Practical imaging of the abdomen.

Equine Vet Educ 2003.

9. Nielsen MK, Donoghue EM, Stephens ML, et al. An ultrasonographic scoring method for transabdominal monitoring of ascarid burdens in foals. Equine Vet J 2016;48:380–386.

A period of gastrointestinal rest supported by continuous rate fluids and parenteral nutrition can be beneficial in neonates presenting with colic.

Image courtesy of Dr. Tiffany L. Hall.

10. Pilati N, Masciarelli AE, Werner LA, et al. Small colon obstruction by an ovarian pedicle as an acquired condition in a foal. Equine Vet Educ 2013.

www.fvma.org |

thefaep |

@thefvma | The Practitioner 17

11. Reef VB. Equine diagnostic ultrasound. Philadelphia, USA: W. B. Saunders Company.; 1998.

12. Russell CM, Wilkins PA. Evaluation of the Recumbent Neonate. Clin Tech Equine Pract 2006.

13. Slovis NM. Gastrointestinal failure. Clin Tech Equine Pract 2003.

Image courtesy of Dr. Tiffany L. Hall.

Tiffany L. Hall,

Nimet Browne,

DVM, DACVIM, DACVECC

DVM, MPH, DACVIM

Dr. Tiffany Hall is an internist and criticalist with the Equine Medical Center of Ocala. Originally from Kentucky, she is a graduate of North Carolina State University College of Veterinary Medicine. Dr. Hall completed her internal medicine residency training at the University of California, Davis followed by a fellowship in emergency and critical care at a private practice in Texas before moving to Florida in 2013. She completed training in acupuncture at the Chi Institute in December 2018. Dr. Hall enjoys the challenge of emergency and critical care medicine and the evaluation of poor performance with a focus on the respiratory, cardiac, and neuromuscular systems. For Tiffany, the most satisfying part of her veterinary career is the long term relationships she has developed with area veterinarians since moving to Ocala.

Dr. Nimet Browne studied veterinary medicine at University of Tennessee, graduating in 2010.

Following veterinar y school, Nimet went on to complete an internship in a private practice in Illinois, then a large animal internal medicine residency at Virginia Tech. During that time, she also obtained a masters in public health with a focus on infectious disease. Following her residency, she completed a yearlong fellowship at Hagyard Equine Medical Institute. In 2016, she took a faculty position in the equine internal medicine department at North Carolina State University but returned to Central Kentucky in 2018. Her interests include neonatal medicine, gastrointestinal disease, infectious disease, and public health. She is currently working on manuscripts regarding infectious causes of diarrhea in neonates as well as the use on enrofloxacin in neonates.

18 The Practitioner

Issue 1 • 2023

Healing horse power.

WITH

Zoetis Regenerative Medicine Devices were created so veterinarians can quickly and easily concentrate regenerative properties from their patients’ blood or bone marrow to supercharge their healing.

Learn more at zoetisus.com/horsepower

All trademarks are the property of Zoetis Services LLC or a related company or a licensor unless otherwise notes. © 2023 Zoetis Services LLC. All rights reserved. PRS-00010R1

A NEW CLASS OF INJECTABLE JOINT THERAPY Arthramid® Vet goes beyond conventional therapies, using a dynamic bio-scaffold technology to safely and sustainably manage osteoarthritis.1

Visit www.ConturaVetUS.com or call 800-689-2909 Veterinary use only. This device is restricted to use by or on the order of a licensed veterinarian.

1

Tnibar, A., Schougaard, H., Camitz, L., Rasmussen, J., Koene, M., Jahn, W., Markussen, B., An international multi-centre prospective study on the efficacy of an intrarticular polyacrylamide hydrogel in horses with osteoarthritis: a 24 month follow up. Acta Vet Scand. 2015; 57: 20-27.

Science + Love.

Helping Horses Thrive.

Our Purina PhD Nutritionists tackle problems using science. And our love of horses keeps us at it until we get it right. Even with our most established feeds, we keep innovating. Even when it takes years of research, we don’t stop until it’s right. We’re dedicated to the scientific method, but it can’t capture the feeling of seeing a horse reach their full potential. It takes science and love to help your horse live their best life.

Put our research to the test at equinevetnutrition.com

© 2023 Purina Animal Nutrition LLC. All rights reserved.

20 The Practitioner

Issue 1 • 2023

Save the Date 2023

OCT. 19-22, 2023

HILTON WEST PALM BEACH

600 Okeechobee Blvd, West Palm Beach, Fla. 33401

Offering world-class, equine-exclusive continuing education TO LEARN MORE, VISIT WWW.FVMA.ORG/ CONFERENCES OR CALL 800.992.3862

www.fvma.org |

thefaep |

@thefvma | The Practitioner 21

Practice Management MANAGING DIFFICULT CLIENTS

and Difficult Expectations

Martha Mallicote | DVM, MBA, DACVIM University of Florida - College of Veterinary Medicine

Excellent client communication improves patient outcomes and quality of care and also protects veterinarians from legal and licensure complaints. Conversely, difficult clients make our ability to provide great veterinary care more challenging and more time-consuming. Let’s unpack the reasons behind client communication challenges and difficult client expectations and how to manage those situations more effectively.

There is a growing body of literature that shows a relationship between quality of communication and outcomes for both patient and practice health. Diagnostic accuracy requires accurate history taking and missed diagnoses often result from breakdowns in history collection (56% of cases in one study).

Studies of doctor-client visits show significant differences in how clients and doctors ask questions, speak, and listen. These differences affect the quality of data collected during the interaction. Improved communication also results in improved client/patient adherence. Several studies have shown that when trust is not established, less information is collected from clients, and follow-up care is not sought. Third, breakdowns in care team communication can compromise the quality and efficiency of patient care.

Ineffective team communication was the root cause for ~66% of reported human medical errors in JCAHO data (1995-2005).

Poor communication can result in an increased risk of formal patient complaints and liability suits. Up to 82% of formal complaints and malpractice cases are due to client perceptions of misinformation or disrespect, lack of informed consent or detailed explanations for a procedure, or a client feeling that their opinion did not matter.

CONSIDERATIONS FOR BUILDING CLIENT TRUST First impressions are incredibly important. Success in this small step requires proactively organizing the ‘welcoming ritual’. Most Americans wish to be addressed by name and want the clinician to introduce themselves. Appropriate touch — often a handshake — is expected and eye contact should be maintained. These two non-verbal components of the introduction are most likely to contribute to a client’s assessment of connectedness.

Image courtesy of Camva.

22 The Practitioner

Nonverbal awareness is key to properly interpreting the client’s response to discussions. About 80% of communication between

Issue 1 • 2023

individuals is nonverbal, and these behaviors are generally involuntary. This means that important information that cannot be hidden is being exchanged at all times — from client to veterinarian and from veterinarian to client. If the client has a concern with veterinary care, it will be signaled in the nonverbal channel, even if they verbally agree with the treatment offered.

Luckily, using nonverbal communication does not require extra time; the doctor can simply notice and respond to those messages as the interaction proceeds.

How we communicate can influence diagnostic accuracy, often by allowing the client the opportunity to tell their story. Failure to get the story, by using a narrow data gathering process, is a missed opportunity for complete diagnostic information. Open-ended questions are key to success in this area, and veterinarians are not always patient enough to do this well.

Active listening presents an opportunity to both get a complete understanding of the case and build rapport with the client. Focus on the client and communicate your attention with nonverbal methods. Reflect back on what the client says by both directly restating key facts and summarizing back the information that has been communicated. Further, the clinician can demonstrate an appreciation of what the experience was like for the client with empathy statements. Empathy is most useful when the client is having an emotional response to information about their pet’s situation. Empathy is the single most important skill in building client relationships, yet it is commonly absent. In one veterinary study, empathy statements were expressed in only 7% of appointments.

About half of all client-veterinarian encounters end with the client unable to repeat the plan of action for their animal. It is key to ensure that the client agrees with and understands the plan, thus tools for ensuring client understanding are essential.

One technique to "close the loop" is the Ask-Tell-Ask Method: 1. Ask the client to describe his/her current understanding of the issue, then; 2. Tell the client in straightforward language what you need to communicate — the bad news, treatment options, or other information — while avoiding medical jargon. Then finally; 3. Assess the client’s understanding. To do this, ask the client to restate what was said in their own words to ensure they fully processed what was said.

DELIVERING “BAD NEWS” Many challenging client communication scenarios center on discussions of “bad news” — whether that be a poor prognosis, an

Image courtesy of Camva.

unexpected outcome, treatment failure or recurrence of disease, need for expensive treatment, and even medical errors. Ultimately, bad news is any information likely to be perceived by the client as distressful, unwanted, and/or unexpected. Particularly when delivering bad news, communication is the veterinarian’s responsibility. It is an essential task that should not be delegated and can have lasting effects on the client and patient. The good news is that effective delivery of bad news can strengthen the client-veterinarian relationship, and clinicians who develop skills for this task will have less stress and burnout.

In one study, about 20% of physicians said that they experienced strong emotions when they had to tell a patient that their medical condition would lead to death. The stress clinicians experience when they give bad news has a different course than the distress patients experience (Shaw et al., 2013). The clinician’s stress peaks during the encounter when the bad news is delivered, whereas the patient’s stress peaks after the encounter as the implications of the bad news are better understood. This mismatch in stress and distress is important to be aware of when delivering bad news to a client. At the very moment a clinician is breathing a sigh of relief (because they successfully delivered bad news), the client is still increasing in stress level.

As already discussed, the use of open-ended questions, reflective listening, and sharing empathy can all help to build rapport with clients. These skills should be again deployed when planning how to deliver bad news. Orient clients to the plan for your encounter when delivering bad news, so that they are prepared for what the conversation will cover. While it is useful to provide a warning that bad news is about to be shared, clients have also been shown to appreciate direct delivery of bad news instead of starting with a long introductory period of information sharing.

www.fvma.org |

thefaep |

@thefvma | The Practitioner 23

Communication is always a two-way interaction and a series of verbal procedures. Like other veterinary procedures, there are degrees of difficulty in various communication procedures, and our clinical skills will improve with deliberate practice. While we cannot change the need to communicate about difficult situations and with difficult clients, the way we communicate can make the process easier for clients and ourselves.

RESOURCES Much of this content is sourced from the IHC Veterinary Communication Project modules. For more information, visit the Institute website at www.healthcarecomm.org and click on Veterinary Communication.

24 The Practitioner

Martha Mallicote,

DVM, MBA, DACVIM Dr. Martha Mallicote completed her undergraduate work at the College of Charleston in South Carolina, completed a master of business administration degree at the University of Florida and is a 2006 graduate of the University of Tennessee College of Veterinary Medicine.

Since graduation, she has worked in both ambulatory and referral hospital settings, including an internal medicine fellowship at Rood and Riddle Equine Hospital. In 2012, Dr. Mallicote completed her residency in large animal internal medicine at the University of Florida and joined the faculty. She was appointed to the Weeks Endowed Professorship in Veterinary Medicine in 2018 by colleagues at the University of Florida. Her professional interests include endocrinology, neonatology, and veterinary business management.

Issue 1 • 2023

ProVet APC TM

A stall side, 3-minute PRP processing system •

• • •

Simple 3-step process with a vertical rotor centrifugation process

30-second spin time; complete processing in 3 minutes Lightweight 4.4 lbs 1 aseptic entry

TO PLACE AN ORDER: (866) 683-0660 ProVet is a registered trademark of Dechra Limited. Dechra is atrademark of Dechra Pharmaceuticals PLC. The ProVet APC system is manufactured by DSM Biomedical, Inc. 04AD-PVT22014-0122

The Next Generation of FLU Protection

Developed to help protect against influenza viruses threatening horses today, the Prestige line of flu vaccines offers the most encompassing and advanced level of protection against equine influenza.

Horses deserve the best protection we can give them. Contact Merck Animal Health or your veterinarian to learn more about the new Prestige line of vaccines. www.merck-animal-health-equine.com

UPDATED INFLUENZA STRAINS INCLUDE:

IN ADDITION TO:

Florida ‘13 Clade 1:

Kentucky ‘02:

Based on a highly pathogenic isolate from the 2013 Ocala, Fla. influenza outbreak that impacted hundreds of horses. Florida ‘13 was exclusively identified and isolated through the Merck Animal Health Biosurveillance Program.

Influenza strain maintained from previous vaccine line.

Richmond ‘07 Clade 2:

The Science of Significant Introducing updated flu strains, only available in the Prestige vaccine line from Merck Animal Health

3834-New-Flu_WhitePony_75x475_CladeInfo.indd 1

Meets World Organisation for Animal Health (OIE) and American Association of Equine Practitioners (AAEP) guidelines for Clade 2 influenza protection.

2 Giralda Farms • Madison, NJ 07940 merck-animal-health-usa.com • 800-521-5767 Copyright © 2018 Intervet Inc., d/b/a/ Merck Animal Health, a subsidiary of Merck & Co., Inc. All rights reserved. 3834-FLUSTRAIN-ADVERTISEMENT

www.fvma.org |

thefaep |

9/14/18 3:35 PM

@thefvma | The Practitioner 25

Add BoneWise® to your treatment plan.

When treating developmental orthopedic disease in growing horses or musculoskeletal injuries in equine athletes, consider research-proven BoneWise.

BoneWise supports strong, resilient bones throughout a horse’s life.

Growing: Supports healthy bone growth and maturation.

In utero: Maintains normal fetal bone development.

BoneWise supplies the unique ingredient Lithothamnion that provides a readily available form of calcium and the trace minerals necessary for strong bones.

Developed by:

Developed by:

Mature athlete: Sustains optimal bone mineral content and bone turnover, which encourages the swift repair of microdamage.

KPPvet.com, 859-873-2974

KPPvet.com, 859-873-2974 Available through all major veterinary suppliers. Sold to veterinarians only.

FAEP 2023 Is 4

Winning in their blood. in their joints.

(Hyaluronic Acid/Chondroitin sulfates C4 & C6/ N-acetyl-D-glucosamine Sterile Solution) · Veterinarian trusted with over a million doses administered since 2006 · High viscosity solution of Hyaluronic Acid + Chondroitin + Glucosamine · Post-Surgical Lavage / Synovial Fluid Replacement / Viscosupplement · Patented formulation

CONSULT YOUR VETERINARIAN

For more information, please visit Polyglycan.com or call 1-888-524-6332.

Veterinary Use Only. Patent Nos.: 6,979,679 / 7,485,629 / 8,455,458. CAUTION: This device is restricted to use by or on the order of a licensed veterinarian. WARNING: Do not administer to animals that are to be slaughtered for use in food. Keep out of reach of children.

Polyglycan ® is a registered trademark of Bimeda, Inc. All rights reserved. © 2023 Bimeda, Inc.

26 The Practitioner

Issue 1 • 2023

!

W E N

Introducing the newest addition to our formulary of equine-friendly compounded medications:

CETIRIZINE HCl 200mg

Apple-Molasses Flavored Gourmeds ®

View pricing and details at

wedgewood.vet/FAEP Mary, Territory Manager, with Calvin FAEP Practitioner Ad 0123.indd 1

1/12/23 1:39 PM

More experience, more service and more expertise. It sums up who we are: a division of Patterson Veterinary dedicated to the way you practice.

We are committed to connecting you with the right products, equipment and management tools to help you run your business efficiently and successfully. And, we back this with comprehensive service and support when and how you need it.

DEDICATION. www.fvma.org |

E Q U I N E DIVISIO N

thefaep |

20PE0003n (10/19)

800.279.6452 | pattersonvet.com/equine

@thefvma | The Practitioner 27

All trademarks are the property of American Regent, Inc. © 2021, American Regent, Inc. PP-AI-US-0375 05/2021

7646 Adequan 2022 HO Half pg Ad FAEP.indd 1

6/24/22 10:42 AM